1.Effect of maternal immune level at different pregnancy stages on cow's milk protein allergy in infants.
Hai-Jun ZHANG ; Xiao-Lei DONG ; Yong-Fa ZHANG ; You-Fu FANG ; Hong-Yu ZHANG
Chinese Journal of Contemporary Pediatrics 2020;22(11):1221-1225
OBJECTIVE:
To study the association between maternal Th1/Th2 immune level at different pregnancy stages and cow's milk protein allergy (CMPA) in infants.
METHODS:
The healthy women with a singleton pregnancy, as well as their offspring, who attended Yidu Central Hospital of Weifang and Qingzhou Traditional Chinese Medicine Hospital from July 2016 to December 2018 were enrolled. The maternal levels of interleukin-2 (IL-2), interferon gamma (IFN-γ), interleukin-4 (IL-4), and interleukin-10 (IL-10) at the second and third trimesters of pregnancy were measured. A CMPA questionnaire survey was conducted within one year after birth. Food avoidance and cow's milk oral challenge tests were performed in infants suspected of CMPA. The 48 infants who met the diagnostic criteria for CMPA were included in the observation group, and the remaining 977 normal infants were included in the control group. A univariate analysis was performed on the infants with CMPA. A Poisson regression analysis was used to determine the association between maternal Th1/Th2 immune factors at different pregnancy stages and CMPA.
RESULTS:
The detection rate of CMPA was 4.68%. The clinical manifestations included the symptoms of the digestive system, skin, and respiratory system and other symptoms. The univariate analysis showed that compared with the control group, the observation group had significantly higher incidence rates of maternal food allergy and maternal history of allergic diseases (P<0.05) and a significantly lower breastfeeding rate (P<0.05). The observation group had significantly lower maternal levels of IL-2 (second and third trimesters) and IFN-γ (third trimester) than the control group (P<0.05). Maternal low IFN-γ at the third trimester and maternal low IL-2 at the second and third trimesters were significantly associated with CMPA in infants (P<0.05). After correction of the factors of breastfeeding, maternal food allergy, and maternal history of allergic diseases, it was found that maternal low IL-2 and IFN-γ at the third trimester were still significantly associated with CMPA in infants (P<0.05).
CONCLUSIONS
The maternal decrease in Th1 level at the third trimester of pregnancy may lead to the change in fetal immunity and thus increase the risk of CMPA in offspring.
Allergens
;
Animals
;
Breast Feeding
;
Cattle
;
Female
;
Humans
;
Infant
;
Milk Hypersensitivity
;
Milk Proteins/immunology*
;
Pregnancy
2.Asia Pacific Association of Allergy Asthma and Clinical Immunology White Paper 2020 on climate change, air pollution, and biodiversity in Asia-Pacific and impact on allergic diseases
Ruby PAWANKAR ; Jiu Yao WANG ; I Jen WANG ; Francis THIEN ; Yoon Seok CHANG ; Amir Hamzah Abdul LATIFF ; Takao FUJISAWA ; Luo ZHANG ; Bernard Yu Hor THONG ; Pantipa CHATCHATEE ; Ting Fan LEUNG ; Wasu KAMCHAISATIAN ; Iris RENGGANIS ; Ho Joo YOON ; Sonomjamts MUNKHBAYARLAKH ; Marysia T. RECTO ; Anne Goh Eng NEO ; Duy LE PHAM ; Le Thi Tuyet LAN ; Janet Mary DAVIES ; Jae Won OH
Asia Pacific Allergy 2020;10(1):11-
Air pollution, climate change, and reduced biodiversity are major threats to human health with detrimental effects on a variety of chronic noncommunicable diseases in particular respiratory and cardiovascular diseases. The extent of air pollution both outdoor and indoor air pollution and climate change including global warming is increasing-to alarming proportions particularly in the developing world especially rapidly industrializing countries worldwide. In recent years, Asia has experienced rapid economic growth and a deteriorating environment and increase in allergic diseases to epidemic proportions. Air pollutant levels in many Asian countries especially in China and India are substantially higher than are those in developed countries. Moreover, industrial, traffic-related, and household biomass combustion, indoor pollutants from chemicals and tobacco are major sources of air pollutants, with increasing burden on respiratory allergies. Here we highlight the major components of outdoor and indoor air pollutants and their impacts on respiratory allergies associated with asthma and allergic rhinitis in the Asia-Pacific region. With Asia-Pacific comprising more than half of the world's population there is an urgent need to increase public awareness, highlight targets for interventions, public advocacy and a call to action to policy makers to implement policy changes towards reducing air pollution with interventions at a population-based level.
Administrative Personnel
;
Air Pollutants
;
Air Pollution
;
Air Pollution, Indoor
;
Allergy and Immunology
;
Asia
;
Asian Continental Ancestry Group
;
Asthma
;
Biodiversity
;
Biomass
;
Cardiovascular Diseases
;
China
;
Climate Change
;
Climate
;
Consumer Advocacy
;
Developed Countries
;
Economic Development
;
Family Characteristics
;
Global Warming
;
Humans
;
Hypersensitivity
;
India
;
Rhinitis, Allergic
;
Tobacco
3.Characteristics of Adult Severe Refractory Asthma in Korea Analyzed From the Severe Asthma Registry.
Min Hye KIM ; Sang Heon KIM ; So Young PARK ; Ga Young BAN ; Joo Hee KIM ; Jae Woo JUNG ; Ji Yong MOON ; Woo Jung SONG ; Hyouk Soo KWON ; Jae Woo KWON ; Jae Hyun LEE ; Hye Ryun KANG ; Jong Sook PARK ; Tae Bum KIM ; Heung Woo PARK ; Kwang Ha YOO ; Yeon Mok OH ; Young Il KOH ; An Soo JANG ; Byung Jae LEE ; Young Joo CHO ; Sang Heon CHO ; Hae Sim PARK ; Choon Sik PARK ; Ho Joo YOON ; You Sook CHO
Allergy, Asthma & Immunology Research 2019;11(1):43-54
PURPOSE: Although mild to moderate asthma is much more common, the morbidity and mortality of severe asthma are much higher. This study was performed to identify and analyze the clinical characteristics of severe asthma in Korea. METHODS: We registered patients with severe refractory asthma into the Severe Asthma Registry supported by the Severe Asthma Work Group of the Korean Academy of Asthma, Allergy and Clinical Immunology. Patients were enrolled since 2010 from the 15 university hospitals nationwide in Korea. Severe asthma was defined according to modified European Respiratory Society/American Thoracic Society criteria. Information on demographics, medical history, pulmonary function tests and skin prick tests was collected; the clinical characteristics of severe asthmatics were analyzed from the collected data. RESULTS: A total of 489 patients were enrolled with a mean age of 62.3; 45% are male. Sixty percent of patients received Global Initiative for Asthma step 4 treatment, and 30% received step 5 treatment. The most common comorbidities were allergic rhinitis (58.7%). Aspirin hypersensitivity was observed in 14.0%. Approximately half (53.9%) are non-smokers. Atopy was proven in 38.5% of the patients. Regarding asthma medications, inhaled corticosteroids and long-acting β-agonist combination inhalers were most commonly prescribed (96.5%), followed by leukotriene antagonists (71.0%). A recombinant anti-immunoglobulin E monoclonal antibody (omalizumab) has been used in 1.8% of the patients. The mean forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1) and FEV1/FVC were 78.7%, 67.5% and 67.9% of predicted values, respectively. The mean Asthma Control Test and quality of life questionnaire scores were 16.5 out of 25 and 59.5 out of 85, respectively. CONCLUSIONS: The baseline characteristics of severe asthma patients in the Korea Severe Asthma Registry were analyzed and reported for the first time. With this cohort, further prospective studies should be performed to search for ways to improve management of severe refractory asthma.
Adrenal Cortex Hormones
;
Adult*
;
Allergy and Immunology
;
Aspirin
;
Asthma*
;
Cohort Studies
;
Comorbidity
;
Demography
;
Forced Expiratory Volume
;
Hospitals, University
;
Humans
;
Hypersensitivity
;
Korea*
;
Leukotriene Antagonists
;
Male
;
Mortality
;
Nebulizers and Vaporizers
;
Prospective Studies
;
Quality of Life
;
Respiratory Function Tests
;
Rhinitis, Allergic
;
Skin
;
Vital Capacity
4.Chronic Food Antigen-specific IgG-mediated Hypersensitivity Reaction as A Risk Factor for Adolescent Depressive Disorder.
Ran TAO ; Zhicheng FU ; Lijun XIAO
Genomics, Proteomics & Bioinformatics 2019;17(2):183-189
Major depressive disorder (MDD) is the most common nonfatal disease burden worldwide. Systemic chronic low-grade inflammation has been reported to be associated with MDD progression by affecting monoaminergic and glutamatergic neurotransmission. However, whether various proinflammatory cytokines are abnormally elevated before the first episode of depression is still largely unclear. Here, we evaluated 184 adolescent patients who were experiencing their first episode of depressive disorder, and the same number of healthy individuals was included as controls. We tested the serum levels of high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-α (TNF-α), IgE, 14 different types of food antigen-specific IgG, histamine, homocysteine, S100 calcium-binding protein B, and diamine oxidase. We were not able to find any significant differences in the serum levels of hs-CRP or TNF-α between the two groups. However, the histamine level of the patients (12.35 μM) was significantly higher than that of the controls (9.73 μM, P < 0.001, Mann-Whitney U test). Moreover, significantly higher serum food antigen-specific IgG positive rates were also found in the patient group. Furthermore, over 80% of patients exhibited prolonged food intolerance with elevated levels of serum histamine, leading to hyperpermeability of the blood-brain barrier, which has previously been implicated in the pathogenesis of MDD. Hence, prolonged high levels of serum histamine could be a risk factor for depressive disorders, and antihistamine release might represent a novel therapeutic strategy for depression treatment.
Adolescent
;
Biomarkers
;
blood
;
C-Reactive Protein
;
Chronic Disease
;
Cytokines
;
Depressive Disorder, Major
;
blood
;
epidemiology
;
etiology
;
Female
;
Food Hypersensitivity
;
blood
;
complications
;
Histamine
;
blood
;
Homocysteine
;
blood
;
Humans
;
Immunoglobulin E
;
blood
;
Immunoglobulin G
;
blood
;
immunology
;
Inflammation Mediators
;
blood
;
Male
;
Risk Factors
;
S100 Calcium Binding Protein beta Subunit
;
blood
;
Young Adult
5.Research progress of mast cell activation-related receptors and their functions.
Yu-Cui JIANG ; Fan YE ; Ying DU ; Zong-Xiang TANG
Acta Physiologica Sinica 2019;71(4):645-656
Mast cells are widely distributed in various parts of the body, especially in the mucosal surface between the body and the external environment. Mast cell is one of the important immune cells and plays important roles in innate immunity, adaptive immunity and immune regulation. Previous researches have shown that excessive activation of mast cells is closely related to the development of allergic and inflammatory diseases such as asthma, allergic rhinitis, food allergies, acute and chronic itching. Mast cells infiltrate into the inflammation site and release various allergic mediators during the occurrence and development of these diseases. Therefore, termination of mast cell activation can be one of the effective methods for the treatment of allergic and inflammatory diseases, and receptors related to mast cell activation are potential targets for the development of anti-allergic drugs. There are many receptors related to mast cell activation, and the effects mediated by different receptors varied from each other. In the recent years, new mast cell receptors are being discovered, but there are not many literatures discussing the possible functions of these newly discovered receptors. This review aims to summarize the receptors involved in mast cell activation and classify related receptors according to their effects.
Asthma
;
immunology
;
Humans
;
Hypersensitivity
;
immunology
;
Immunity, Innate
;
Inflammation
;
immunology
;
Mast Cells
;
cytology
;
immunology
6.Current Management of Moderate-to-Severe Atopic Dermatitis: A Survey of Allergists, Pediatric Allergists and Dermatologists in Korea.
Hye Yung YUM ; Hyun Hee KIM ; Hyun Jung KIM ; Woo Kyung KIM ; So Yeon LEE ; Kapsok LI ; Dong Hun LEE
Allergy, Asthma & Immunology Research 2018;10(3):253-259
PURPOSE: There is an unmet need for the treatment of moderate-to-severe atopic dermatitis (AD), leading to variation in management strategies. To investigate distinct features and treatment modalities according to physicians' specialties, we collected data on the current treatment approach to moderate-to-severe AD among allergists, pediatric allergists and dermatologists in Korea. METHODS: This questionnaire-based study was administered to physicians from the Korean Academy of Asthma, Allergy and Clinical Immunology (KAAACI), Korean Academy of Pediatric Allergy and Respiratory Disease (KAPARD), and Korean Atopic Dermatitis Association (KADA). RESULTS: A total of 93 physicians participated in the study; 64.5% were pediatric allergists and 31.2% were dermatologists. The major patient age groups were “less than 5 years” for 100% of pediatric allergists and “6–12 years old” for 38% of dermatologists. The proportion of patients with moderate-to-severe AD was higher for dermatologists and allergists compared to pediatric allergists. Physicians agreed on the necessity of education including demonstration of basic skin care and application of topical therapies (88.2%), nutritional consultation (83.9%) and psychological counseling (75.3%). However, less than half were able to educate and counsel their patients in real practice. There were noticeable differences in first-line treatment among physician groups. For pediatric allergists, the order of preferred systemic treatment was wet wrap therapy, systemic corticosteroids and oral cyclosporin. Dermatologists ranked cyclosporin, phototherapy, and systemic corticosteroids as first-line treatment regimens. Major reported barriers to proper management were steroid phobia, unproven complementary and alternative medicine, lack of education, and the unreasonable insurance system. CONCLUSIONS: Our findings suggest there are distinct differences in moderate-to-severe AD treatment according to physicians' specialties. Medical policy changes along with governmental supports are required in order to implement the ideal approach in real practice. For moderate-to-severe AD, a consensus on the approach to optimal management should be reached for the best outcomes, based on further randomized controlled trials.
Adrenal Cortex Hormones
;
Allergy and Immunology
;
Asthma
;
Complementary Therapies
;
Consensus
;
Counseling
;
Cyclosporine
;
Dermatitis, Atopic*
;
Education
;
Humans
;
Hypersensitivity
;
Insurance
;
Korea*
;
Phobic Disorders
;
Phototherapy
;
Skin Care
7.Perceptions of Severe Asthma and Asthma-COPD Overlap Syndrome Among Specialists: A Questionnaire Survey.
Sang Heon KIM ; Ji Yong MOON ; Jae Hyun LEE ; Ga Young BAN ; Sujeong KIM ; Mi Ae KIM ; Joo Hee KIM ; Min Hye KIM ; Chan Sun PARK ; So Young PARK ; Hyouk Soo KWON ; Jae Woo KWON ; Jae Woo JUNG ; Hye Ryun KANG ; Jong Sook PARK ; Tae Bum KIM ; Heung Woo PARK ; You Sook CHO ; Kwang Ha YOO ; Yeon Mok OH ; Byung Jae LEE ; An Soo JANG ; Sang Heon CHO ; Hae Sim PARK ; Choon Sik PARK ; Ho Joo YOON
Allergy, Asthma & Immunology Research 2018;10(3):225-235
PURPOSE: Severe asthma and asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) are difficult to control and are often associated with poor clinical outcomes. However, much is not understood regarding the diagnosis and treatment of severe asthma and ACOS. To evaluate the current perceptions of severe asthma and COPD among asthma and COPD specialists, we designed an e-mail and internet-based questionnaire survey. METHODS: Subjects were selected based on clinical specialty from among the members of the Korean Academy of Asthma, Allergy and Clinical Immunology and the Korean Academy of Tuberculosis and Respiratory Diseases. Of 432 subjects who received an e-mail invitation to the survey, 95 subjects, including 58 allergists and 37 pulmonologists, responded and submitted their answers online. RESULTS: The specialists estimated that the percentage of severe cases among total asthma patients in their practice was 13.9%±11.0%. Asthma aggravation by stepping down treatment was the most common subtype, followed by frequent exacerbation, uncontrolled asthma despite higher treatment steps, and serious exacerbation. ACOS was estimated to account for 20.7% of asthma, 38.0% of severe asthma, and 30.1% of COPD cases. A history of smoking, persistently low forced expiratory volume in 1 second (FEV1), and low FEV1 variation were most frequently classified as the major criteria for the diagnosis of ACOS among asthma patients. Among COPD patients, the highly selected major criteria for ACOS were high FEV1 variation, positive bronchodilator response, a personal history of allergies and positive airway hyperresponsiveness. Allergists and pulmonologists showed different assessments and opinions on asthma phenotyping, percentage, and diagnostic criteria for ACOS. CONCLUSIONS: Specialists had diverse perceptions and clinical practices regarding severe asthma and ACOS patients. This heterogeneity must be considered in future studies and strategy development for severe asthma and ACOS.
Allergy and Immunology
;
Asthma*
;
Diagnosis
;
Electronic Mail
;
Forced Expiratory Volume
;
Humans
;
Hypersensitivity
;
Lung Diseases, Obstructive
;
Population Characteristics
;
Pulmonary Disease, Chronic Obstructive
;
Smoke
;
Smoking
;
Specialization*
;
Tuberculosis
8.Comparison between Newly Developed and Commercial Inhalant Skin Prick Test Reagents Using In Vivo and In Vitro Methods.
Sang Chul LEE ; Da Woon SIM ; Jongsun LEE ; Kyoung Yong JEONG ; Kyung Hee PARK ; Jae Hyun LEE ; Jung Dong KIM ; Jung Won PARK
Journal of Korean Medical Science 2018;33(13):e101-
BACKGROUND: We developed skin prick test (SPT) reagents for common inhalant allergens that reflected the real exposure in Korea. The study aim was to evaluate diagnostic usefulness and allergen potency of our inhalant SPT reagents in comparison with commercial products. METHODS: We produced eight common inhalant allergen SPT reagents using total extract (Prolagen): Dermatophagoides farinae, Dermatophagoides pteronyssinus, oak, ragweed, mugwort, Humulus japonicus pollens, as well as cat and dog allergens. We compared the newly developed reagents with three commercially available SPT reagents (Allergopharma, Hollister-Stier, Lofarma). We measured total protein concentrations, sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), major allergen concentration, and biological allergen potencies measured by immunoglobulin E (IgE) immunoblotting and ImmunoCAP inhibition test. RESULTS: Diagnostic values of these SPT reagents were expressed as positivity rate and concordance rate of the results from ImmunoCAP allergen-specific IgE test in 94 allergic patients. In vitro analysis showed marked differences in protein concentrations, SDS-PAGE features, major allergen concentrations, and biological allergen potencies of four different SPT reagents. In vivo analysis showed that positive rates and concordance rates of Prolagen® SPT reagents were similar compared to the three commercial SPT reagents. CONCLUSION: The newly developed Prolagen® inhalant SPT reagents are not inferior to the commercially available SPT reagents in allergy diagnosis.
Allergens
;
Allergy and Immunology
;
Ambrosia
;
Animals
;
Artemisia
;
Cats
;
Dermatophagoides farinae
;
Dermatophagoides pteronyssinus
;
Diagnosis
;
Dogs
;
Electrophoresis
;
Electrophoresis, Polyacrylamide Gel
;
Humans
;
Humulus
;
Hypersensitivity
;
Immunoblotting
;
Immunoglobulin E
;
Immunoglobulins
;
In Vitro Techniques*
;
Indicators and Reagents*
;
Korea
;
Methods*
;
Pollen
;
Skin*
;
Sodium
9.Immune Homeostasis: Effects of Chinese Herbal Formulae and Herb-Derived Compounds on Allergic Asthma in Different Experimental Models.
Lu LIU ; Lin-Peng WANG ; Shan HE ; Yan MA
Chinese journal of integrative medicine 2018;24(5):390-398
Allergic asthma is thought to arise from an imbalance of immune regulation, which is characterized by the production of large quantities of IgE antibodies by B cells and a decrease of the interferon-γ/interleukin-4 (Th1/Th2) ratio. Certain immunomodulatory components and Chinese herbal formulae have been used in traditional herbal medicine for thousands of years. However, there are few studies performing evidence-based Chinese medicine (CM) research on the mechanisms and effificacy of these drugs in allergic asthma. This review aims to explore the roles of Chinese herbal formulae and herb-derived compounds in experimental research models of allergic asthma. We screened published modern CM research results on the experimental effects of Chinese herbal formulae and herb-derived bioactive compounds for allergic asthma and their possible underlying mechanisms in English language articles from the PubMed and the Google Scholar databases with the keywords allergic asthma, experimental model and Chinese herbal medicine. We found 22 Chinese herb species and 31 herb-derived anti-asthmatic compounds as well as 12 Chinese herbal formulae which showed a reduction of airway hyperresponsiveness, allergen-specifific immunoglobulin E, inflflammatory cell infifiltration and a regulation of Th1 and Th2 cytokines in vivo, in vitro and ex vivo, respectively. Chinese herbal formulae and herbderived bioactive compounds exhibit immunomodulatory, anti-inflflammatory and anti-asthma activities in different experimental models and their various mechanisms of action are being investigated in modern CM research with genomics, proteomics and metabolomics technologies, which will lead to a new era in the development of new drug discovery for allergic asthma in CM.
Animals
;
Asthma
;
complications
;
drug therapy
;
immunology
;
Disease Models, Animal
;
Drugs, Chinese Herbal
;
therapeutic use
;
Homeostasis
;
Hypersensitivity
;
complications
;
drug therapy
;
immunology
;
Immunologic Factors
;
therapeutic use
10.Allergic disease-related articles in Korean newspapers (1920–1972 year).
Allergy, Asthma & Respiratory Disease 2018;6(Suppl 1):S85-S89
PURPOSE: This study aimed to investigate which Korean newspaper articles were reported on allergic diseases before the establishment of the Korean Academy of Asthma, Allergy and Clinical Immunology (KAAACI). METHODS: This study was performed in 3 newspapers, Chosun Ilbo, DongA Ilbo, and JoongAng Ilbo, which were founded and used the databases established before the establishment of KAAACI in 1972. The databases were searched using 42 keywords associated with allergic diseases (allergy, asthma, rhinitis, etc.). RESULTS: Among the 42 keywords, there were only 7 that were able to search: allergy, urticaria, asthma, dermatitis, rhinitis, pollen and eczema. The total number of articles related to allergic diseases were 62, as follows: allergy (n=21), urticaria (n=15), asthma (n=8), dermatitis (n=8), rhinitis (n=5), pollen (n=3), and eczema (n=2). There were 31 articles in Chosun Ilbo, 9 in DongA Ilbo, and 22 in JoongAng Ilbo. The first allergic disease published in the newspapers was asthma on the article entitled “Treat the cause of asthma” (on page 8 of November 10, 1960 DongA Ilbo). The first article that used the term allergy appeared in a column entitled, “Childhood illness and allergy” (on page 4 of May 30, 1960 DongA Ilbo). CONCLUSION: Since 1920, articles related to allergic diseases published in the Korean newspapers increased every year. These articles may have appeared due to the increase in the prevalence of allergic disease and the pioneering efforts of senior allergy researchers.
Allergy and Immunology
;
Asthma
;
Dermatitis
;
Eczema
;
Hypersensitivity
;
Korea
;
Periodicals*
;
Pollen
;
Prevalence
;
Rhinitis
;
Urticaria

Result Analysis
Print
Save
E-mail